Evidence map›Paper›PMID 37753448›Full record

ArticleEClinicalMedicine2023

Deep learning-based model detects atrial septal defects from electrocardiography: a cross-sectional multicenter hospital-based study.

Kotaro Miura, Ryuichiro Yagi, Hiroshi Miyama, Mai Kimura, Hideaki Kanazawa, Masahiro Hashimoto, Sayuki Kobayashi, Shiro Nakahara, Tetsuya Ishikawa, Isao Taguchi and 8 more

Open access · goldAbstract read
In one paragraph

Article in EClinicalMedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 2 countries.

Kotaro MiuraDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Ryuichiro YagiDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, USA.
Hiroshi MiyamaDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Mai KimuraDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Hideaki KanazawaDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Masahiro HashimotoDepartment of Radiology, Keio University School of Medicine, Tokyo, Japan.
Sayuki KobayashiDepartment of Cardiology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.
Shiro NakaharaDepartment of Cardiology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.
Tetsuya IshikawaDepartment of Cardiology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.
Isao TaguchiDepartment of Cardiology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.
Motoaki SanoDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Kazuki SatoInstitute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan.
Keiichi FukudaDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Rahul C DeoDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, USA.
Calum A MacRaeDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, USA.
Yuji ItabashiDepartment of Cardiology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.
Yoshinori KatsumataDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Shinichi GotoDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Keio University · JPSocial Insurance Saitama Chuo Hospital · JPBrigham and Women's Hospital · US

Funding

Machine learning for the automated identification and tracking of rare myocardial diseasesR01HL140731 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MACRAE, CALUM A., SHAH, SANJIV J · 2018 to 2021
$2.8M
NHLBI NIH HHS R01 HL140731
6 · The paper itself

Abstract

Background: Atrial septal defect (ASD) increases the risk of adverse cardiovascular outcomes. Despite the potential for risk mitigation through minimally invasive percutaneous closure, ASD remains underdiagnosed due to subtle symptoms and examination findings. To bridge this diagnostic gap, we propose a novel screening strategy aimed at early detection and enhanced diagnosis through the implementation of a convolutional neural network (CNN) to identify ASD from 12-lead electrocardiography (ECG). Methods: ECGs were collected from patients with at least one recorded echocardiogram at 3 hospitals from 2 continents (Keio University Hospital from July 2011 to December 2020, Brigham and Women's Hospital from January 2015 to December 2020, and Dokkyo Medical University Saitama Medical Center from January 2010 and December 2021). ECGs from patients with a diagnosis of ASD were labeled as positive cases while the remainder were labeled as negative. ECGs after the closure of ASD were excluded. After randomly splitting the ECGs into 3 datasets (50% derivation, 20% validation, and 30% test) with no patient overlap, a CNN-based model was trained using the derivation datasets from 2 hospitals and was tested on held-out datasets along with an external validation on the 3rd hospital. All eligible ECGs were used for derivation and validation whereas the earliest ECG for each patient was used for the test and external validation. The discrimination of ASD was assessed by the area under the receiver operating characteristic curve (AUROC). Multiple subgroups were examined to identify any heterogeneity. Findings: A total of 671,201 ECGs from 80,947 patients were collected from the 3 institutions. The AUROC for detecting ASD was 0.85-0.90 across the 3 hospitals. The subgroup analysis showed excellent performance across various characteristics Screening simulation using the model greatly increased sensitivity from 80.6% to 93.7% at specificity 33.6% when compared to using overt ECG abnormalities. Interpretation: A CNN-based model using 12-lead ECG successfully identified the presence of ASD with excellent generalizability across institutions from 2 separate continents. Funding: This work was supported by research grants from JST (JPMJPF2101), JSR corporation, Taiju Life Social Welfare Foundation, Kondou Kinen Medical Foundation, Research fund of Mitsukoshi health and welfare foundation, Tokai University School of Medicine Project Research and Internal Medicine Project Research, Secom Science and Technology Foundation, and Grants from AMED (JP23hma922012 and JP23ym0126813). This work was partially supported by One Brave Idea, co-funded by the American Heart Association and Verily with significant support from AstraZeneca and pillar support from Quest Diagnostics.

Indexed as

Artificial intelligenceAtrial septal defectDeep learningElectrocardiography

Identifiers

PMID37753448
PMCPMC10518511
OpenAlexW4385955726

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.